Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
2.58
Nov 13 • 3:59 PM ET Dollar change0.00 Percentage change(0.00%)
Nov 13, 5:33 AMHyperion DeFi turns core-profitable, beats Q3 guidance, reiterates higher 2026 profit outlook
Index
-
Market Cap
40.09M
Enterprise Value
34.18M
Income
-3.58M
Sales
1.91M
Book/sh
9.20
Cash/sh
0.43
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
9
IPO
Jan 25, 2018
P/E
-
Forward P/E
1.66
PEG
-
P/S
20.99
P/B
0.28
P/C
6.06
P/FCF
-
EV/EBITDA
-
EV/Sales
17.90
Quick Ratio
3.76
Current Ratio
3.76
Debt/Eq
0.00
LT Debt/Eq
0.00
Option/Short
No / Yes
EPS (ttm)
-2.26
EPS next Y
1.55
EPS next Q
0.47
EPS this Y
161.49%
EPS next Y
-73.18%
EPS next 5Y
-
EPS past 3/5Y
47.93% 34.01%
Sales past 3/5Y
- -16.47%
EPS Y/Y TTM
90.06%
Sales Y/Y TTM
452.71%
EPS Q/Q
2168.57%
Sales Q/Q
167.90%
Insider Own
17.53%
Insider Trans
0.29%
Inst Own
20.19%
Inst Trans
-2.58%
ROA
34.58%
ROE
37.22%
ROIC
27.87%
Gross Margin
-
Oper. Margin
-820.78%
Profit Margin
-187.38%
SMA20
-10.32%
SMA50
-22.17%
SMA200
-22.60%
Trades
Shs Outstand
15.44M
Shs Float
12.82M
52W High
5.34 -51.69%
52W Low
2.34 10.26%
Volatility
7.28% 8.46%
ATR (14)
0.26
RSI (14)
39.51
Beta
2.76
Rel Volume
0.00
Avg Volume
459.61K
Volume
0
Perf Week
3.61%
Perf Month
-18.10%
Perf Quarter
-9.15%
Perf Half Y
-23.21%
Perf YTD
-27.53%
Perf Year
-48.09%
Perf 3Y
-97.29%
Perf 5Y
-99.15%
Perf 10Y
-
Prev Close
2.58
Price
2.58
Change %
0.00%
Consensus
Strong Buy
Avg. Price Target
$10.22
Implied Upside
+296.1%
Analysts5incl. previous ratings
Rating Distribution3 Buy · 2 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Dec 24, 2025Initiated
CChardan Capital Markets
Buy
Dec 16, 2025Initiated
CCantor Fitzgerald
Overweight$4+55.0%
Nov 18, 2024Downgrade
HH.C. Wainwright
Buy → Neutral$12 → $2-22.5%
Mar 01, 2021Initiated
NNorthland Capital
Outperform$10+287.6%
Feb 03, 2020Downgrade
OPY logoOOppenheimer
Outperform → Perform
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jung HyunsuSee RemarksJun 01 '26Buy3.707,00025,9201,384,676Jun 02 06:18 PM
Jung HyunsuSee RemarksJun 02 '26Buy3.661,0003,6601,385,676Jun 02 06:18 PM
Knox David R.Chief Financial OfficerDec 31 '25Buy3.5927,950100,340327,950Jan 05 08:00 AM
Strahlman Ellen RDirectorDec 29 '25Buy3.6012,11243,60391,161Dec 30 04:01 PM
Strahlman Ellen RDirectorDec 29 '25Buy3.6111,85642,80034,869Dec 30 04:01 PM
Strahlman Ellen RDirectorDec 26 '25Buy3.863,60113,91179,049Dec 30 04:01 PM
Strahlman Ellen RDirectorDec 26 '25Buy3.863,31112,77723,013Dec 30 04:01 PM
Strahlman Ellen RDirectorDec 18 '25Buy3.1419,70261,83595,150Dec 22 08:15 AM
Strahlman Ellen RDirectorDec 18 '25Buy3.1418,74258,82975,448Dec 22 08:15 AM
Walters Happy DavidDirectorDec 17 '25Buy3.0261,930187,152111,930Dec 19 07:21 PM
GELTZEILER MICHAEL SDirectorDec 17 '25Buy3.0130,00090,21088,015Dec 19 11:00 AM
Hyperion DeFi, Inc. is a long-term strategic treasury of Hyperliquid's native token HYPE. The firm provides investors with streamlined access to the Hyperliquid ecosystem and is also developing its proprietary Optejet user-filled device, designed for use with a variety of topical ophthalmic liquids, including artificial tears and lens rewetting products. It operates through the following segments: Ophthalmic Technology and Digital Assets. The Ophthalmic Technology segment focuses on developing eye-care devices and delivery systems for ophthalmic liquids. The Digital Assets segment focuses on managing a strategic treasury of blockchain-based assets and exposure to the Hyperliquid ecosystem. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in Laguna Hills, CA.
CEOMr. Hyunsu Jung
Chief Financial Officer and TreasurerMr. David Knox C.F.A.
General Counsel & SecretaryMr. Robert Rubenstein
Investor ContactJason Assad
Investor ContactAlexander Lobo